REGENXBIO and AbbVie Advance Wet AMD Gene Therapy to Phase III
Phase I/IIa data for a single dose of REGENEXBIO’s gene therapy, RGX-314, shows promise for treating wet age-related macular degeneration.
Phase I/IIa data for a single dose of REGENEXBIO’s gene therapy, RGX-314, shows promise for treating wet age-related macular degeneration.
A vocal brain region is identified in bats and leveraged in comparative genomic analyses to reveal the evolution of mammalian vocal behavior.
Senescent cells displayed more proinflammatory, metabolically deregulated, and pathology-associated signatures
Genie learns how to control games by watching hours and hours of video. It could help train next-gen robots too.
Academic chapter and two books authored by Francesca Gino appear to copy from sources including student theses, blogs, and news reports
Targeting of GALT by anti-α4β7 therapy is associated with therapeutic responses in ulcerative colitis.
Micro supercapacitors have emerged as a promising alternative providing higher power density, rapid charging capabilities, and long lifespan.
Bioluminescence, which has evolved many times across the tree of life, is more ancient than previously thought
France is at a crossroads, facing environmental and social challenges that are profoundly altering its society. Yet, the French government keeps prioritizing short-term political gains…
The increases are welcome news, but fall short of an advisory group’s recommendation
Excitement among patients and researchers as custom-built jabs enter phase 3 trial